Hyundai Pharmaceutical Market Cap

Hyundai Pharmaceutical has a market cap or net worth of 362.85 billion as of February 25, 2026. Its market cap has increased by 277.27% in one year.

Market Cap

362.85B

Enterprise Value

n/a

Revenue

108.14B

Ranking

n/a

PE Ratio

217.28

Stock Price

12,610.00

Market Cap Chart

Since August 30, 1995, Hyundai Pharmaceutical's market cap has increased from 28.77B to 362.85B, an increase of 1,161.01%. That is a compound annual growth rate of 8.66%.

Market Cap History

Date	Market Cap	% Change
Feb 25, 2026	362.85B	53.87%
Dec 30, 2025	235.81B	137.66%
Dec 30, 2024	99.22B	-12.77%
Dec 28, 2023	113.76B	-14.20%
Dec 29, 2022	132.58B	-19.22%
Dec 30, 2021	164.12B	-22.93%
Dec 30, 2020	Upgrade Pro	Upgrade Pro
Dec 30, 2019	Upgrade Pro	Upgrade Pro
Dec 28, 2018	Upgrade Pro	Upgrade Pro
Dec 28, 2017	Upgrade Pro	Upgrade Pro
Dec 29, 2016	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Dong-A ST	506.47B
Humedix	476.79B
Yungjin Pharm.	379.50B
Huons	338.48B
BNC Korea	322.82B
CMG Pharmaceutical	310.47B
JW Holdings	309.28B
Korea United Pharm	305.29B

Market Cap Rankings